Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management

Status unconfirmed

Conditions studied: Pain, Chronic Pain, Back Pain, Nociceptive Pain, Neuropathic Pain, Musculoskeletal Pain, Neck Pain, Pain, Intractable

In brief

The purpose of this study is to evaluate the impact of genetic testing on healthcare decisions and patient outcomes in interventional pain management clinical care. Results of genetic testing will also be compared with the clinical outcome measures collected to discover novel genetic factors that may influence patient care.

Key facts

Study ID
NCT02485795
Run by
Proove Bioscience, Inc.
People needed
50000
Starts
2014-09-01
Expected to finish
2017-08-01
Last updated by the study team
2017-06-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.